CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+8.48%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$14.8B
AUM Growth
+$630M
(+4.4%)
Cap. Flow
-$386M
Cap. Flow
% of AUM
-2.61%
Top 10 Holdings %
Top 10 Hldgs %
24.14%
Holding
926
New
50
Increased
255
Reduced
457
Closed
57
Top Buys
| 1 |
Mercado Libre
MELI
|
+$41.1M |
| 2 |
Darling Ingredients
DAR
|
+$37M |
| 3 |
Johnson & Johnson
JNJ
|
+$34.5M |
| 4 |
Veru
VERU
|
+$34M |
| 5 |
MetLife
MET
|
+$31.5M |
Top Sells
| 1 |
PepsiCo
PEP
|
+$46.7M |
| 2 |
Nike
NKE
|
+$42.5M |
| 3 |
Illinois Tool Works
ITW
|
+$37M |
| 4 |
Gilead Sciences
GILD
|
+$32.3M |
| 5 |
Merck
MRK
|
+$30.3M |
Sector Composition
| 1 | Healthcare | 33.31% |
| 2 | Technology | 22.85% |
| 3 | Financials | 10.04% |
| 4 | Consumer Discretionary | 7.69% |
| 5 | Industrials | 7.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
676
Encompass Health
EHC
$12.6B
| $937K | 0.01% |
15,660
-4,247
| -21% | -$254K |
|
677
Phathom Pharmaceuticals
PHAT
$874M
| $935K | 0.01% |
83,357
-28,678
| -26% | -$322K |
|
|
SGFY
678
DELISTED
Signify Health, Inc.
SGFY
| $934K | 0.01% |
32,601
| – | – |
|
679
Theravance Biopharma
TBPH
$687M
| $933K | 0.01% |
83,202
-19,626
| -19% | -$220K |
|
680
Atea Pharmaceuticals
AVIR
$250M
| $933K | 0.01% |
193,956
+64,627
| +50% | +$311K |
|
681
Brown & Brown
BRO
$30.5B
| $924K | 0.01% |
+16,227
| New | +$924K |
|
682
Aclaris Therapeutics
ACRS
$221M
| $924K | 0.01% |
58,647
+2,368
| +4% | +$37.3K |
|
683
Ligand Pharmaceuticals
LGND
$3.24B
| $905K | 0.01% |
+13,546
| New | +$905K |
|
684
Alector
ALEC
$287M
| $904K | 0.01% |
97,938
+5,825
| +6% | +$53.8K |
|
685
Varex Imaging
VREX
$455M
| $902K | 0.01% |
44,424
-432
| -1% | -$8.77K |
|
686
Autoliv
ALV
$9.63B
| $900K | 0.01% |
11,758
-5,420
| -32% | -$415K |
|
687
Canadian Natural Resources
CNQ
$64.9B
| $899K | 0.01% |
32,410
| – | – |
|
688
Merit Medical Systems
MMSI
$5.26B
| $886K | 0.01% |
12,544
-4,183
| -25% | -$295K |
|
689
Enbridge
ENB
$106B
| $886K | 0.01% |
22,679
-4,714
| -17% | -$184K |
|
690
Castle Biosciences
CSTL
$665M
| $885K | 0.01% |
37,595
+3,172
| +9% | +$74.7K |
|
691
Kimco Realty
KIM
$15.1B
| $883K | 0.01% |
41,712
-9,142
| -18% | -$194K |
|
692
Enovis
ENOV
$1.74B
| $879K | 0.01% |
16,428
-3,239
| -16% | -$173K |
|
693
Teledyne Technologies
TDY
$25.6B
| $879K | 0.01% |
2,198
| – | – |
|
|
PDCO
694
DELISTED
Patterson Companies, Inc.
PDCO
| $874K | 0.01% |
31,182
-6,826
| -18% | -$191K |
|
695
Bunge Global
BG
$16.5B
| $871K | 0.01% |
8,730
-12,560
| -59% | -$1.25M |
|
696
Camden Property Trust
CPT
$11.6B
| $866K | 0.01% |
7,744
-1,502
| -16% | -$168K |
|
697
Senseonics Holdings
SENS
$357M
| $865K | 0.01% |
839,866
+255,926
| +44% | +$264K |
|
698
Mesa Laboratories
MLAB
$327M
| $856K | 0.01% |
5,150
-726
| -12% | -$121K |
|
699
Adaptive Biotechnologies
ADPT
$1.89B
| $856K | 0.01% |
111,982
+1,489
| +1% | +$11.4K |
|
700
Henry Schein
HSIC
$8.17B
| $854K | 0.01% |
10,688
-2,180
| -17% | -$174K |
|